Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Ligand Lands $2 Million Payment From Merck

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

On Monday, Ligand Pharmaceuticals (Nasdaq: LGND  ) confirmed that Merck (NYSE: MRK  ) will pay it a $2 million milestone payment, as the latter begins phase 2b/3 clinical trials of a new cancer drug.

Ligand believes the drug in question, dinaciclib -- originally developed by Ligand acquisition Pharmacopoeia -- offers "significant potential in oncology" and has licensed the drug to Merck for use in treating chronic lymphocytic leukemia.

The news comes too late to save Ligand's third quarter, with the company warning investors this week that absent the $2 million payment, its Q3 revenues are going to fall about 25% short of previous expectations. As the money shifts into Q4, however, Ligand was able to up guidance for Q4 by about 18%, to $13 million.

Two million dollars is about 6.7% of the $30 million in revenues Ligand expects to collect this year. Ligand reports Q3 earnings on Nov. 5.

Fool contributor Rich Smith and The Motley Fool have no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2071631, ~/Articles/ArticleHandler.aspx, 10/25/2016 9:10:28 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,169.27 -53.76 -0.30%
S&P 500 2,143.16 -8.17 -0.38%
NASD 5,283.40 -26.43 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/25/2016 4:00 PM
LGND $93.29 Down -0.70 -0.74%
Ligand Pharmaceuti… CAPS Rating: ***
MRK $61.95 Up +1.20 +1.98%
Merck and Co. CAPS Rating: ****